Skip to main content
Livermore
Livermore
ZHEN

Leonteq Securities AG

SEC CIK
0001535950
Latest filing
Jul 27, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Leonteq Securities AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
484
Value
$145.7K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ALNY by Leonteq Securities AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026484$145.7K<0.1%+236+95.2%AddedHolders
Q1 2026248$82.1K<0.1%+143+136.2%AddedHolders
Q4 2025105$41.8K<0.1%+102+3,400.0%AddedHolders
Q3 20253$1.37K<0.1%−26−89.7%ReducedHolders
Q2 202529$9.46K<0.1%−3−9.4%ReducedHolders
Q1 202532$9.07K<0.1%−115−78.2%ReducedHolders
Q4 2024147$34.6K<0.1%+52+54.7%AddedHolders
Q3 202495$26.1K<0.1%+95NewHolders
Q2 20240$00.0%−1,850−100.0%Sold outHolders
Q1 20241,850$276.5K<0.1%+1,408+318.6%AddedHolders
Q4 2023442$84.6K<0.1%−141−24.2%ReducedHolders
Q3 2023583$103.2K<0.1%−128−18.0%ReducedHolders
Q2 2023711$135.0K<0.1%−96−11.9%ReducedHolders
Q1 2023807$161.7K<0.1%+194+31.6%AddedHolders
Q4 2022613$145.7K<0.1%−525−46.1%ReducedHolders
Q3 20221,138$227.8K<0.1%−96−7.8%ReducedHolders
Q2 20221,234$180.0K<0.1%−245−16.6%ReducedHolders
Q1 20221,479$241.5K<0.1%+713+93.1%AddedHolders
Q4 2021766$129.9K<0.1%−1,012−56.9%ReducedHolders
Q3 20211,778$335.7K<0.1%−245−12.1%ReducedHolders
Q2 20212,023$342.9K<0.1%−892−30.6%ReducedHolders
Q1 20212,915$411.6K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.